Home page

Industry News丨Experts "high-profile delivery" SARS-CoV-2 home self-test, Synthgene OTC products are complete!

Since the outbreak of the epidemic, due to the better control of the epidemic than other countries in the world, the nucleic acid detection capacity basically meets the detection needs. my country mainly implements epidemic prevention measures with nucleic acid detection as the main method. Antibody and antigen detection are only used as auxiliary detection methods in a small area. application. European and American countries mainly adopt the epidemic prevention method of COVID-19 antigen home testing, so many domestic IVD companies have received orders from overseas for COVID-19 antigen home testing reagents.

17

2022

/

03

CACLP丨 Synthgene invites you to "prosper" to enjoy the diagnosis ceremony together!

CACLP丨 Synthgene invites you to "prosper" to enjoy the diagnosis ceremony together!

From March 27th to 29th, 2022, Synthgene will participate in the 19th China International Medical and Blood Transfusion Instrument and Reagent Expo (CACLP) held in Nanchang International Expo Center.

04

2022

/

03

During the exhibition丨Meeting with the world, Synthgene made a stunning appearance at Medlab in Dubai in 2022!

During the exhibition丨Meeting with the world, Synthgene made a stunning appearance at Medlab in Dubai in 2022!

The 2022 Middle East Dubai International Medical Laboratory Instrument and Equipment Exhibition (Medlab Middle East) was grandly opened on January 24 at the Dubai World Trade Center in the United Arab Emirates. As the world's largest exhibition of laboratory equipment and inspection products, Medlab 2022 has welcomed more than 3,500 exhibitors and more than 56,000 professional visitors from more than 60 countries around the world. Synthgene brought a variety of products to Dubai Medlab in 2022, attracting much attention!

25

2022

/

01

The event is in progress | The 53rd MEDICA opened grandly, looking back on the wonderful first day of Synthgene Medical Technology!

The event is in progress | The 53rd MEDICA opened grandly, looking back on the wonderful first day of Synthgene Medical Technology!

On November 15, 2021, the world's largest medical equipment industry exhibition, the German International Hospital and Medical Equipment Supplies Exhibition (MEDICA), grandly opened in Dusseldorf, Germany. This MEDICA exhibition attracted more than 200,000 exhibitors from more than 100 countries, and experts from various countries gathered to discuss and exchange medical cutting-edge technology. For the first time of MDICIA, Synthgene Medical Technology showed a variety of products, which attracted much attention.

16

2021

/

11

SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit developed by Nanjing Synthgene Medical was successfully registered with the National Medical Products Administration of Ukraine

SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit developed by Nanjing Synthgene Medical was successfully registered with the National Medical Products Administration of Ukraine

SARS-COV-2 Nucleocapsid (N) Antigen Rapid Detection Kit developed by Nanjing Synthgene Medical was successfully registered with the National Medical Products Administration of Ukraine.

29

2021

/

10

< 1...5 6 7 8 >

Nanjing Synthgene Medical Technology Co., Ltd.

Nanjing Synthgene Medical Technology Co., Ltd. is a biomedical high-tech enterprise focusing on the development and production of OTC home self-inspection products. The company has a mature technology platform, including chromatography platform, isothermal amplification platform, etc.

Messages

Messages

whatsapp

whatsapp

Tel

+86 17721538411

E-mail

E-mail

TOP

Contact Us

Address：Building B6-2, No. 9, Weidi Road, Xianlin University Town, Xianlin Subdistrict, Qixia District, Nanjing City, China
Tel: +86 17721538411

Email: info@syngenebio.com

After-sale Email ： service@syngenebio.com

Copyright © Nanjing Synthgene Medical Technology Co., Ltd. | SEO | Powered by： www.300.cn

Business License

Close

Inquiry

Total X Clear all